U.S. Real Estate Stock News

Wondering whether Workiva is starting to look attractively priced or still too expensive at around US$59.77 per share? This article breaks down what that price could imply about value. The stock is up 1.8% over the last 7 days, while the 1 year return sits at a 9.4% loss and the year to date return is a 28.0% loss, with a 30 day return of a 7.9% loss. Recent coverage around Workiva has focused on how the share price performance contrasts with its longer term track record, which includes a...

If you are wondering whether Occidental Petroleum at around US$62.96 offers value or is primarily driven by sentiment, this article walks through the numbers so you can assess the price tag with more confidence. The stock recently saw a 5.0% decline over the last 7 days, alongside a 16.2% gain over 30 days and returns of 48.6% year to date and 66.0% over 1 year. Recent attention on Occidental Petroleum has focused on its role in the US energy sector and how investors interpret its exposure...

Global Business Travel Group (GBTG) is back on investor radar after options activity showed elevated implied volatility in certain call contracts. This coincides with UBS reaffirming its rating while trimming expectations and the company maintaining its 2026 guidance. See our latest analysis for Global Business Travel Group. At a share price of US$5.56, Global Business Travel Group has seen short term momentum soften, with a 7 day share price return of 2.96% set against a 90 day share price...

Over the last 7 days, the United States market has risen by 3.5%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on price discrepancies relative to their intrinsic value.

The United States market has shown impressive strength, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In such a robust environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors seeking to diversify their portfolios.

Porch Group, Inc. ( NASDAQ:PRCH ) is possibly approaching a major achievement in its business, so we would like to...

Readers hoping to buy Accenture plc ( NYSE:ACN ) for its dividend will need to make their move shortly, as the stock is...

The United States market has experienced a notable upswing, rising 3.5% over the past week and an impressive 31% over the last year, with earnings projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained revenue expansion and innovation.

The United States market has experienced a robust performance, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying promising small-cap stocks can be key to unlocking potential opportunities that may not yet be fully recognized by the broader market.

CEVA, Inc. ( NASDAQ:CEVA ), might not be a large cap stock, but it saw a decent share price growth of 14% on the...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

The Morning Bull - US Market Morning Update Monday, Apr, 6 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.7% and Nasdaq 100 futures up just over 1%, as investors weigh a mix of strong jobs data and signs of cooling inflation. Nonfarm payrolls rose by 178,000 in March while unemployment sits at 4.3% and wage growth is 3.5% year on year, suggesting more people are working but pay pressures are easing. At the same time, the US Services PMI has...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

We can readily understand why investors are attracted to unprofitable companies. Indeed, vTv Therapeutics ( NASDAQ:VTVT...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

CSG Systems International (NasdaqGS:CSGS) has entered a significant partnership with ePLDT Group to support digital solutions and enterprise services in the Philippines. The collaboration extends CSG’s platform solutions into a new Southeast Asian market within the region’s information and communications technology sector. The agreement focuses on helping enterprise clients streamline and manage their digital offerings across a growing set of services. CSG Systems International, known for...

Context for recent stock performance With no single headline event driving attention to JBG SMITH Properties (JBGS), the focus for investors has centered on its recent share performance and operating profile in Washington, DC centered mixed-use real estate. See our latest analysis for JBG SMITH Properties. The recent 1 day share price return of 0.83% decline and 90 day share price return of 14.65% decline signal fading short term momentum. At the same time, the 3 year total shareholder return...

Why Hologic (HOLX) is on investors’ radar today Hologic (HOLX) has drawn investor interest recently as its share price, which last closed at US$75.65, reflects mixed short term performance and a moderate gain over the past 3 months. Over the past month, Hologic’s return was roughly flat, while the past 3 months show a gain of about 1%. Over the past year, the stock’s total return of about 24% contrasts with a slight negative total return over 3 years and a modest gain over 5 years. These...

Recently, activist investor Land & Buildings raised its stake in Centerspace REIT to 9.19%, coinciding with Board Member Emily Nagle Green’s retirement and the declaration of a quarterly dividend. Taken together, the larger activist presence and board change may point to upcoming discussions around Centerspace’s capital allocation and portfolio direction. With Land & Buildings now owning over 9% of Centerspace, we’ll examine how this increased activist involvement could reshape its...

Why Sealed Air Is On Investors’ Radar Sealed Air (SEE) has been drawing attention after recent share price moves, prompting investors to take a fresh look at its packaging business, current valuation signals, and how its returns have varied across different time frames. See our latest analysis for Sealed Air. The share price at US$42.08 has been relatively steady in the short term, while the 1 year total shareholder return of 76.16% contrasts with flat to slightly negative total shareholder...

In recent months, Soleno Therapeutics has faced multiple securities class action lawsuits alleging that the company and certain executives failed to disclose material safety concerns and data integrity issues tied to the Phase 3 program for its Prader‑Willi syndrome drug DCCR, marketed as VYKAT XR. These legal challenges, centered on claims of undisclosed risks such as fluid retention, diabetes‑related markers, and high discontinuation rates, have intensified scrutiny of VYKAT XR’s clinical...

For investors wondering if Turning Point Brands at around US$72.16 is still offering value or if the easy gains are behind it, this article focuses squarely on what the current price might be implying. The stock has pulled back sharply in the short term, with a 15.5% decline over the last 7 days and a 21.9% decline over the last 30 days, even though the 1 year return sits at 32.8% and the 3 year return is 254.2%. Recent market attention has centered on how this performance, including a year...

Royalty Pharma (NasdaqGS:RPRX) has entered into a new R&D co-funding agreement with Johnson & Johnson to develop a novel autoimmune therapy. The company has also appointed a Head of Artificial Intelligence to expand the use of advanced analytics and data science across its operations. These announcements mark a shift toward greater involvement in drug development and data driven decision making. Royalty Pharma, known primarily for acquiring biopharma royalties, typically gives investors...

Regulators allowed the Hart Scott Rodino antitrust waiting period for Coterra Energy's merger with Devon Energy to expire, clearing a key hurdle. This approval means Coterra Energy (NYSE:CTRA) can move toward closing, with the company expected to become a wholly owned subsidiary of Devon. The companies currently anticipate closing the transaction in Q2 2026, subject to remaining customary conditions. Coterra Energy focuses on oil and gas exploration and production, an area where scale, cost...